JP2001518477A5 - - Google Patents

Download PDF

Info

Publication number
JP2001518477A5
JP2001518477A5 JP2000513868A JP2000513868A JP2001518477A5 JP 2001518477 A5 JP2001518477 A5 JP 2001518477A5 JP 2000513868 A JP2000513868 A JP 2000513868A JP 2000513868 A JP2000513868 A JP 2000513868A JP 2001518477 A5 JP2001518477 A5 JP 2001518477A5
Authority
JP
Japan
Prior art keywords
glucopyranosyl
frost
ene
galactopyranoside
triol
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2000513868A
Other languages
English (en)
Other versions
JP2001518477A (ja
JP4338306B2 (ja
Filing date
Publication date
Priority claimed from CN97119680A external-priority patent/CN1131237C/zh
Application filed filed Critical
Publication of JP2001518477A publication Critical patent/JP2001518477A/ja
Publication of JP2001518477A5 publication Critical patent/JP2001518477A5/ja
Application granted granted Critical
Publication of JP4338306B2 publication Critical patent/JP4338306B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Description

本発明に従い、式IIの好ましい化合物は、
(25S)−26−O−β−D−グルコピラノシル−22−ヒドロキシ−5β−フロスト−2β,3β,26−トリオール−3−O−β−D−グルコピラノシル(1→2)−β−D−ガラクトピラノシド、
(25S)−26−O−β−D−グルコピラノシル−22−メトキシ−5β−フロスト−2β,3β,26−トリオール−3−O−β−D−グルコピラノシル(1→2)−β−D−ガラクトピラノシド、
(25S)−26−O−β−D−グルコピラノシル−5β−フロスト−20(22)−エン−2β,3β,26−トリオール−3−O−β−D−グルコピラノシル(1→2)−β−ガラクトピラノシド、
(25R)−26−O−β−D−グルコピラノシル−22−ヒドロキシ−5−エン−フロスト−3β,26−ジオール−3−O−β−D−グルコピラノシル(1→4)−β−D−ガラクトピラノシド、
(25R)−26−O−β−D−グルコピラノシル−22−メトキシ−5−エン−フロスト−3β,26−ジオール−3−O−β−D−グルコピラノシル(1→4)−β−D−ガラクトピラノシド、
(25R)−26−O−β−D−グルコピラノシル−5−エン−フロスト−20(22)−エン−3β,26−ジオール−3−O−β−D−グルコピラノシル(1→4)−β−D−ガラクトピラノシド
より成る群から選択される。
JP2000513868A 1997-09-26 1998-09-28 痴呆の予防または治療のためのステロイドサポニンの使用、及び新規なステロイドサポニン化合物 Expired - Fee Related JP4338306B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CN97119680.X 1997-09-26
CN97119680A CN1131237C (zh) 1997-09-26 1997-09-26 甾体皂甙防治老年性痴呆的用途及新的甾体皂甙
PCT/CN1998/000204 WO1999016786A1 (fr) 1997-09-26 1998-09-28 Utilisation de composes de saponine et de steroides pour prevenir la senilite et nouveaux composes de saponine steroide

Publications (3)

Publication Number Publication Date
JP2001518477A JP2001518477A (ja) 2001-10-16
JP2001518477A5 true JP2001518477A5 (ja) 2009-06-18
JP4338306B2 JP4338306B2 (ja) 2009-10-07

Family

ID=5175496

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2000513868A Expired - Fee Related JP4338306B2 (ja) 1997-09-26 1998-09-28 痴呆の予防または治療のためのステロイドサポニンの使用、及び新規なステロイドサポニン化合物

Country Status (9)

Country Link
US (1) US6593301B1 (ja)
EP (1) EP1024146B1 (ja)
JP (1) JP4338306B2 (ja)
KR (1) KR100354826B1 (ja)
CN (1) CN1131237C (ja)
AU (1) AU9336098A (ja)
CA (1) CA2304770C (ja)
DE (1) DE69841421D1 (ja)
WO (1) WO1999016786A1 (ja)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9923076D0 (en) 1999-09-29 1999-12-01 Phytopharm Plc Sapogenin derivatives and their use
US20030118673A1 (en) * 1998-03-26 2003-06-26 Zongqin Xia Smilagenin and anzurogenin-D for the treatment of alzheimer's disease
JP3768100B2 (ja) 1998-03-26 2006-04-19 ファイトファーム・ピーエルシー アルツハイマー病を治療するためのステロイドサポゲニンとその誘導体
GB9905275D0 (en) 1999-03-08 1999-04-28 Phytopharm Ltd Treatment of conditions associated with membrane-bound receptors and their function
GB2347676A (en) 1999-03-08 2000-09-13 Phytopharm Plc Screening method
GB9923078D0 (en) * 1999-09-29 1999-12-01 Phytopharm Plc Sapogenin derivatives and their use
GB9923077D0 (en) * 1999-09-29 1999-12-01 Phytopharm Plc Sapogenin derivatives and their use
GB0000228D0 (en) * 2000-01-06 2000-03-01 Phytopharm Plc Fluoro substituted sapogenins and their use
CN1422861A (zh) * 2001-12-03 2003-06-11 张晓� 皂甙化合物的用途
CA2479249A1 (en) * 2002-03-15 2003-09-25 Samaritan Pharmaceuticals, Inc. Neuroprotective spirostenol pharmaceutical compositions
US20050130948A1 (en) * 2002-03-27 2005-06-16 Daryl Rees Therapeutic methods and uses of sapogenins and their derivatives
NZ563183A (en) * 2002-03-27 2009-03-31 Phytopharm Plc Therapeutic methods and uses of sapogenins and their derivatives
CN102727501A (zh) * 2002-03-27 2012-10-17 菲特法姆股份有限公司 皂角苷配基及其衍生物的用途
KR20100093621A (ko) * 2002-03-27 2010-08-25 파이토팜 피엘씨 사포게닌 및 그 유도체의 치료 방법 및 용도
AU2003229877B8 (en) * 2002-03-27 2008-06-12 Phytopharm Plc Theraputic methods and uses of sapogenins and their derivatives
US20060009433A1 (en) * 2003-03-14 2006-01-12 Zhi-Xing Yao Neuroprotective spirostenol pharmaceutical compositions
GB0513881D0 (en) 2005-07-06 2005-08-10 Btg Int Ltd Core 2 GLCNAC-T Inhibitors III
GB0329667D0 (en) * 2003-12-22 2004-01-28 King S College London Core 2 GlcNAc-T inhibitor
US20080182801A1 (en) * 2003-12-22 2008-07-31 Btg International Limited Core 2 glcnac-t inhibitors
CN100427500C (zh) * 2004-04-29 2008-10-22 中国人民解放军军事医学科学院放射医学研究所 知母皂苷bⅱ的制备方法
CN1692914B (zh) * 2004-04-29 2010-05-26 中国人民解放军军事医学科学院放射医学研究所 知母皂苷bⅱ在制备用于防治脑卒中药物或产品中的用途
CN1315866C (zh) * 2004-05-09 2007-05-16 上海正祥天然药物科技有限公司 天冬总甾体皂苷提取物及其制备方法与应用
CN1732955B (zh) * 2004-08-03 2011-02-09 山东绿叶制药有限公司 以知母总皂苷元为活性成分的药物组合物及其制备方法和用途
CN1754541A (zh) * 2004-09-30 2006-04-05 成都地奥制药集团有限公司 甾体皂苷药物组合物及其制备方法和用途
CA2584333A1 (en) * 2004-10-14 2006-04-27 Georgetown University Neuroprotective spirostenol pharmaceutical compositions
KR20080036552A (ko) * 2005-05-17 2008-04-28 사토리 파마슈티컬즈, 인코포레이티드 신경퇴행성 장애를 치료하는 데 유용한 화합물
GB0512726D0 (en) * 2005-06-22 2005-07-27 Btg Int Ltd Multiple sclerosis therapy and diagnosis
GB0513888D0 (en) * 2005-07-06 2005-08-10 Btg Int Ltd Core 2 GLCNAC-T Inhibitors II
JP5166272B2 (ja) * 2005-10-28 2013-03-21 キム・スンヨウ ヤマノイモ科植物の抽出物、及びこれを含む末梢神経障害の予防用または治療用の組成物
EP2274317A4 (en) * 2008-04-30 2012-10-24 Inst Radiation Med Amms Pla SYNTHESIS OF TIMOSAPONINE BII
EP2389182A1 (en) 2009-01-24 2011-11-30 Phytopharm PLC Treatment of neurotrophic factor mediated disorders
CN102311481B (zh) * 2010-07-01 2012-12-05 中国科学院上海药物研究所 毛红椿酸甲酯及其制备方法和用途
US20130210786A1 (en) 2010-07-20 2013-08-15 Patrick Alexander Howson Treatment of l-dopa, dopamine agonist and/or dopamine enhancer induced disorders
KR101341693B1 (ko) * 2011-03-16 2013-12-16 동아에스티 주식회사 생약추출물을 함유하는 퇴행성 신경질환의 치료 및 예방을 위한 조성물
WO2013149580A1 (en) * 2012-04-03 2013-10-10 Chiming Che Timosaponin compounds
KR101777920B1 (ko) * 2015-07-27 2017-09-14 재단법인 지능형 바이오 시스템 설계 및 합성 연구단 진세노사이드 f1을 포함하는 아밀로이드 플라크 제거용 조성물
CN105153266B (zh) * 2015-07-30 2017-03-22 中国人民解放军第四军医大学 一种甾体皂苷类化合物及其在制备抗肿瘤药物中的应用
US20190060341A1 (en) * 2015-10-16 2019-02-28 Instituto Tecnológico y de Estudios Superiores de Monterrey Agavaceae extract comprising steroidal saponins to treat or prevent metabolic disorder related pathologies
CN105440098B (zh) * 2015-12-31 2017-04-19 南京中医药大学 一种制备知母皂苷n的方法
CN107488204A (zh) * 2017-08-17 2017-12-19 烟台大学 达玛烷型人参皂苷(元)及其ocotillol型衍生物的抗炎用途

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1144136B (it) * 1980-03-05 1986-10-29 Zenyaku Kogyo Kk Glucosidi di condurango agenti antitumorali che li comprendono e procedimento per la loro preparazione
JP2631686B2 (ja) * 1988-03-01 1997-07-16 湧永製薬株式会社 新規ステロイドサポニンおよびその製造法ならびにこれらの誘導体の新規用途
JPH02243631A (ja) * 1989-03-15 1990-09-27 Wakunaga Pharmaceut Co Ltd 抗発癌プロモーター
JPH0454194A (ja) * 1990-06-19 1992-02-21 Wakunaga Pharmaceut Co Ltd 新規ステロイド配糖体およびこの製造法ならびにこれを有効成分とする血糖降下剤
CN1088748A (zh) * 1993-01-01 1994-07-06 赵广才 荞麦保健食品
DE4303214A1 (de) * 1993-02-04 1994-08-11 Wolfgang Marks Behandlung von Erkrankungen viraler, viroidaler oder onkogener Genese durch Steroid-Saponine oder deren Aglykone
US5502038A (en) * 1993-06-21 1996-03-26 Medical Research Foundation Of Oregon Cholesterol sequestrant glycosides that inhibit intestinal cholesterol absorption
CN1102186A (zh) * 1993-10-29 1995-05-03 沈阳医学院 中药薤白新成分的鉴定及用途
JPH07267864A (ja) * 1994-03-28 1995-10-17 Tsumura & Co 体温降下剤
JPH0859476A (ja) * 1994-08-22 1996-03-05 Shiratori Seiyaku Kk 肝炎治療剤
CN1138984A (zh) * 1995-06-26 1997-01-01 军事医学科学院放射医学研究所 新型甙类抗血栓药物
KR0169536B1 (ko) * 1996-02-27 1999-01-15 손경식 신규한 인삼 사포닌, 그의 제조방법 및 이를 유효성분으로 하는 항종양제

Similar Documents

Publication Publication Date Title
JP2001518477A5 (ja)
NO20010050L (no) Fremgangsmåte for å forbedre söthetsavlevering av sukralose
JP2002524024A5 (ja)
NO995540L (no) Preparat omfattende findelte, krystallinske partikler av budesonid
CA2209825A1 (en) Heterocyclic-fused pyridines
NO20011272L (no) Fremgangsmåte for fremstilling av ren citalopram
JP2003510332A5 (ja)
EE04120B1 (et) Viirusevastase bensimidasoolühendi kristallilisedvormid
NO20010833D0 (no) Orale mukoadhesive sammensetninger inneholdende gastrointestinale aktive bestanddeler
NO20005121D0 (no) FremgangsmÕte for fremstilling av kaliumsulfat
CA2326815A1 (en) Process for preparation of pyridine derivatives
NO941173L (no) Fremgangsmåte for opparbeiding av residue fra organoklorsilansyntese
NO20024956L (no) Fremgangsmåte for fremstilling av ionebyttemembraner
JP2000169695A5 (ja)
NO20000456D0 (no) Fremgangsmåte for fremstilling av 1,2-dikloretan
NO20000432D0 (no) Fremgangsmåte for fremstilling av 1,2-dikloretan ved oksyklorering
JP2003238140A5 (ja)
JP2000021571A5 (ja)
CA2328832A1 (en) Processes for preparing pesticidal intermediates
WO2001051486A3 (en) Process and intermediates for the preparation of imidazopyridines
NO941174D0 (no) Fremgangsmåte for opparbeiding av silisiumrike, uopplöste rester fra utluting av kobberholdige residuer fra organoklorsilansyntese
JP2001523698A5 (ja)
NO20011652D0 (no) Fremgangsmåte for fremstilling av 1,5-diaryl-3-substituerte pyrazoler
NO981467L (no) FremgangsmÕte for fremstilling av etere fra alkoholer
EE200300402A (et) (E)-5-(2-bromovinüül)-2'-desoksüuridiini valmistamise meetod